Primary Care Diabetes
Volume 1, Issue 4 , Pages 185-186 , December 2007

Rosiglitazone and the thiazolidinediones: A changing context

  • Colin Kenny

      Affiliations

    • Corresponding Author InformationTel.: +44 28692758; fax: +44 28693145.

Received 21 October 2007

References 

  1. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med. 2004;351:1106–1118
  2. Singh S, Loke YK, Furberg CD. Thiazolidinediones and heart failure: A Teleo-analysis. Diab. Care. 2007;30:2148–2153
  3. Home PD, et al. Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis. N. Engl. J. Med. 2007;357:28–38
  4. Investigators, D.R.E.A.M., Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368 (2006) 1096–1105.
  5. Khan SE, Haffner SM, Heise MA. Glycaemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 2006;355:2443–2457
  6. Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–1289
  7. Eurich DTMF, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ. 2007;335:497
  8. Rzonca SO, Suva LJ, Gaddy D, et al. Bone is a target for antidiabetic compound rosiglitazone. Endocrinology. 2004;183:203–216
  9. Grey A. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J. Clin. Endocrinol. Metab. 2007;92(4):1305–1310
  10. Yaturu S, Bryant B, Jain SK. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diab. Care. 2007;30(6):1574–1576
  11. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 2007;356(14):2457–2471
  12. Psaty BM, Furberg CD. The record on rosiglitazone and the risk of myocardial infarction. N. Engl. J. Med. 2007;357(1):67–69
  13. Editorial, Rosiglitazone: seeking a balanced perspective. Lancet 369 (9576) (2007) 1834.
  14. Shuster JJ, Jones LS, Salmon DA. Fixed vs. random effects meta-analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death. Statist. Med. 2007;26:4375–4385
  15. Singh S, Lobe YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone a meta-analysis. JAMA. 2007;298:1189–1195
  16. Goldberg RB. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diab. Care. 2005;28(7):1547–1554
  17. Gerrits CM, Bhattacharya M, Manthena S. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetics. Pharmacoepidemiol. Drug Saf. 2007;16(10):1065–1071
  18. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus meta-analysis of randomized trials. JAMA. 2007;298:1180–1188
  19. Richter B, Bergerhoff K, Clar C, Ebrahim Sh. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2007;
  20. Bolen S, Feldman L, Vassy J. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann. Intern. Med. 2007;147:386–399
  21. Rosen C. The Rosiglitazone Story—Lessons from an FDA Advisory Committee Meeting. N. Engl. J. Med. 2007;357:844–846
  22. Kazi D. Rosiglitazone and implications for pharmacovigilance. BMJ. 2007;334:1233–1234
  23. Solomon DH, Winkelmayer WC. Cardiovascular risk and the thiazolidinediones—deja vu all over again?. JAMA. 2007;298(10):1216–1218

PII: S1751-9918(07)00150-7

doi: 10.1016/j.pcd.2007.10.043

Primary Care Diabetes
Volume 1, Issue 4 , Pages 185-186 , December 2007

Article Tools